We are a life science business development consulting firm based in California. Connecting businesses in North America and Asia.

Get to know more about our firm
Life Science, Strategic Partnerships
Spreading great science and innovation to the world, regardless of origin, with a keen attention to transparency, trust, and long-term relationships that extend beyond a single transaction.
MedCI Timeline
What our clients say
I have known members of the MedCI team for over 20 years. When it comes to closing a partnership in Asia/Japan, I would work with no other firm
Ray Warrell CEO, Relburn Pharmaceuticals
The team at MedCI was of tremendous help in identifying and assisting in negotiations with our partner in Japan. MedCI continues to work with us in facilitating communications in the post transaction phase. Their cultural knowledge and connections were invaluable in helping to make a deal happen. We were, and continue to be, very pleased with their efforts
Peter Geiger CFO, Perfusio Corporation
When we were looking to license our platform technology in the US and Japan, MedCI came highly recommended and we couldn’t have been happier with our decision to go with them. The MedCI team provided excellent insights, guidance, and stewardship during the entire deal process with Takeda
Seijin Park CFO, Legochem Biosciences
Bridging the Gap
We offer business development services for the biopharmaceutical and medical device industries. Based in Santa Clara, California, we operate throughout the United States as well as Japan and South Korea, and through an affiliate in China.
Conceived in 2004 with the premise that Asia will play an increasingly important role in the global healthcare industry, we help companies out-license and in-license biopharmaceutical and medical device assets and technologies – from preclinical to marketed.
After an initial focus of licensing late-stage innovative biopharmaceuticals from the US to South Korea, MedCI expanded its geographical reach to include Japan and China in 2012 and 2013, respectively. Since 2017, MedCI has been increasingly involved with helping Asia-based biopharmaceutical companies with business development activities in the US. In 2021, we expanded our expertise to include medical devices.
Led by a highly experienced and cross-functional team with deep industry networks, MedCI garners a holistic understanding of the technology and marketing impact to provide diverse perspectives and solutions to complex issues and, ultimately, meaningful results to our clients. Our approach is firmly anchored by an intimate understanding of the cultural nuances and business etiquettes of international business that smooths discussions and fosters goodwill.
In this industry, there are no off-the-shelf or one-size-fits-all solutions. We bring a boutique philosophy to each transaction, giving a small number of clients the high level of attention they need to build valuable and long-term relationships with business partners.

